DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in BSX — Boston Scientific Corp
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in BSX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$830,160,158
-$937,694,916 QoQ
Shares Held
13,229,644
-28.6% QoQ
Ownership
0.890%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 46.383077277060515.ToString("F0")%
Shared 0.ToString("F0")%
None 53.616922722939485.ToString("F0")%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Derivatives in BSX
reported options exposure · as of Mar 31, 2026CallValue
$58,796,750
CallShares
937,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Mar 31, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $2,401,312,514 across 15 Medical Devices names. BSX ranks #2 (34.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
12,811,902 | $1,025,977,110 | |
| 2 | BSX |
Boston Scientific Corp
This page
|
13,229,644 | $830,160,158 | |
| 3 | MDT |
Medtronic plc
|
4,625,639 | $400,811,615 | |
| 4 | DXCM |
Dexcom Inc
|
799,465 | $50,206,401 | |
| 5 | ABT |
Abbott Laboratories
|
365,322 | $37,507,607 | |
| 6 | SYK |
Stryker Corp
|
101,288 | $33,282,221 | |
| 7 | CNMD |
CONMED Corp
|
311,469 | $11,013,543 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
89,819 | $6,393,315 |
All Filings in BSX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $58,796,750 | 937,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $830,160,158 | 13,229,644 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,767,855,074 | 18,540,693 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,369,996,976 | 14,032,541 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,784,673,968 | 16,615,529 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,790,041,349 | 17,744,264 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,992,994,211 | 22,312,967 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,823,368,919 | 21,758,579 | Shares | Defined | 2026-05-04 | |
| 2024-06-30 | $1,716,152,599 | 22,284,802 | Shares | Defined | 2026-05-04 | |
| 2024-03-31 | $1,412,546,594 | 20,624,129 | Shares | Defined | 2026-05-04 | |
| 2023-12-31 | $1,221,682,426 | 21,132,718 | Shares | Defined | 2026-05-04 | |
| 2023-09-30 | $1,177,342,530 | 22,298,154 | Shares | Defined | 2026-05-04 | |
| 2023-06-30 | $1,162,508,985 | 21,492,124 | Shares | Defined | 2026-05-04 | |
| 2023-03-31 | $1,173,084,827 | 23,447,628 | Shares | Defined | 2024-05-17 | |
| 2022-12-31 | $1,082,433,576 | 23,393,853 | Shares | Defined | 2024-05-17 | |
| 2022-09-30 | $841,774,163 | 21,734,422 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $775,444,985 | 20,806,144 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $740,420,508 | 16,717,555 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $419,720,027 | 9,880,415 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $546,506,854 | 12,595,226 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $658,298,494 | 15,395,194 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $554,314,047 | 14,341,890 | Shares | Defined | 2026-05-04 | |
| 2020-12-31 | $273,745,479 | 7,614,617 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $231,179,287 | 6,050,230 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $121,946,789 | 3,473,278 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $242,813,141 | 7,441,408 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||